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Abstract Fetal alcohol spectrum disorder (FASD) is an
umbrella term used to describe the craniofacial dysmorphic
features, malformations, and disturbances in growth, neu-
rodevelopment and behavior occurring in individuals pre-
natally exposed to alcohol. Fetal alcohol syndrome (FAS)
represents the severe end of this spectrum. Many patho-
physiological mechanisms have hitherto been proposed to
account for the disrupted growth and morphogenesis seen
in FAS. These include impaired cholesterol-modification
of the Sonic hedgehog morphogen, retinoic acid deficien-
cy, lipoperoxidative damage due to alcohol-induced reac-
tive oxygen species combined with reduced antioxidant
defences, and malfunctioning cell adhesion molecules.
In this report, we propose a completely novel concept
regarding the pathogenesis of FAS. Based on our obser-
vation that transferrin isoelectric focusing (TIEF) – the
most widely used screening tool for congenital disorders
of glycosylation (CDG) – was transiently abnormal in a
newborn with FAS and a confirmed maternal history of
gestational alcohol abuse, we came to believe that FAS
exemplifies a congenital disorder of glycosylation sec-
ondary to alcohol-inflicted disruption of (N-linked) pro-
tein glycosylation. Various pieces of evidence were
found in the literature to substantiate this hypothesis.
This observation implies, among others, that one might
need to consider the possibility of maternal alcohol
consumption in newborns with transient glycosylation
abnormalities. We also present an integrated pathophys-
iological model of FAS, which incorporates all existing
theories mentioned above as well as our novel concept.
This model highlights the pivotal role of disrupted iso-
prenoid metabolism in the origination of FAS.
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Abbreviations
α1-AT Alpha-1-antitrypsin
CDG Congenital disorders of glycosylation
CNS Central nervous system
Dol-P Dolichol phosphate
ER Endoplasmic reticulum
FAS Fetal alcohol syndrome
FASD Fetal alcohol spectrum disorder
GA Golgi apparatus
LLO Lipid-linked oligosaccharide
PSA-NCAM Polysialic acid neural cell adhesionmolecules
RA Retinoic acid
ROS Reactive oxygen species
(T)IEF (Transferrin) isoelectric focusing
Introduction
In 1973, Jones and Smith launched the term fetal alcohol
syndrome (FAS) to describe a characteristic pattern of al-
tered fetal growth and morphogenesis due to maternal alco-
hol consumption during pregnancy (Jones and Smith 1973).
Nowadays, the effects of prenatal alcohol exposure are
collectively referred to as fetal alcohol spectrum disorder
(FASD). The following anomalies are generally considered
key elements of FASD: 1) prenatal and/or postnatal growth
retardation, 2) dysmorphic facial features, mainly affecting
the premaxillary region (smooth philtrum, thin vermillion
border of the upper lip, short palpebral fissures), 3) alcohol-
related birth defects, such as cardiac, skeletal, renal and
ocular malformations, and 4) alcohol-related neurodevelop-
mental disorders, which include structural central nervous
system (CNS) abnormalities (microcephaly, partial or com-
plete corpus callosum agenesis, cerebellar hypoplasia, and
leptomeningeal heterotopias) as well as behavioral, cogni-
tive, and motor disabilities (Van Balkom et al. 1996;
Chudley et al. 2005). FAS epitomizes the most severe form
of FASD. The degree to which offspring is affected by
maternal alcohol ingestion depends on the timing and level
of exposure, with more serious disruptions in fetus exposed
to high concentrations of alcohol during the first weeks of
pregnancy (Chudley et al. 2005; Guizzetti and Costa 2007;
Kot-Leibovich and Fainsod 2009; Lipinski et al. 2010). FAS
has an estimated incidence of 1–3 per 1000 live births and,
as such, constitutes the principal cause of non-inherited
mental retardation (Van Balkom et al. 1996; Chudley et al.
2005; Guizzetti and Costa 2007; Abdelrahman and Conn
2009). Multiple pathophysiological models have hitherto
been proposed to account for the phenotypic appearance of
FAS, most of which will be discussed below. None of these,
however, fully clarifies the entire spectrum of alcohol-
related disorders.
Observation and hypothesis
In a series of 200 patients aged 0–24 months, prospectively
screened for congenital disorders of glycosylation (CDG)
because of hypotonia and/or psychomotor developmental
delay, we encountered a male newborn demonstrating a
false positive screening result. This boy was the first child
of healthy parents. There was a positive history of smoking
and alcohol consumption during pregnancy. He was born at
term, small for gestational age and treated for perinatal
group B streptococcal disease. He had abnormal alpha-1-
antitrypsin (α1-AT) electrophoresis, neonatal hypoglyce-
mia, elevated liver transaminases and developed axial hy-
potonia, increased deep tendon reflexes and mild peripheral
spasticity. Initial screening at the age of 1 week showed
abnormal transferrin isoelectric focusing (TIEF). At the
age of 3 months, biochemical re-evaluation showed normal
results for TIEF, isoelectric focusing of thyroglobulin and
α1-AT, as well as normal phosphomannose-mutase (PMM2)
and phosphomannose-isomerase (PMI) enzyme analyses.
Based on characteristic dysmorphic features (short palpebral
fissures, epicanthal folds, hypoplastic midface, short nose,
long philtrum, inverted nipples, short terminal phalanges of
the fifth fingers and atrial septal defect) and the pregnancy
history, he was later diagnosed with FAS. His clinical course
was further complicated by developmental delay, speech
delay and epilepsy.
The false positive screening for CDG – i.e., the transient-
ly abnormal TIEF pattern – in this patient with a later
diagnosis of FAS made us aware of a possible pathophysi-
ological link between CDG and FAS. We therefore studied
the literature to find evidence to verify our hypothesis that
FAS can be regarded as a CDG secondary to prenatal
alcohol exposure. Moreover, we composed a comprehensive
pathophysiological model of FAS, which incorporates all
existing theories as well as our own novel concept.
Existing theories
Cholesterol deficiency and Sonic hedgehog dysfunction
Cholesterol is an end product of the mevalonate pathway
(Edison and Muenke 2004). For later discussion, it is im-
portant to mention that intermediates of this pathway are
commonly referred to as isoprenoids, for they contain a
variable number of isoprene units. Smith-Lemli-Opitz syn-
drome (SLOS) is the most common inherited defect in this
biosynthetic pathway. It is caused by mutations in the 7-
dehydrocholesterol reductase gene, the enzyme product of
which catalyzes the final reaction of cholesterol biosynthe-
sis, i.e., the conversion of 7-dehydrocholesterol to choles-
terol. SLOS and FAS have strikingly similar phenotypes,
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both in humans and animal models, which corroborates the
contention that cholesterol deficiency plays a pathophysio-
logical role in FAS (Guizzetti and Costa 2007). Cholesterol
is crucial for normal development. In addition to being a
regulator of membrane fluidity and permeability, a precursor
for steroid hormones, a substrate for glial cell proliferation
and synaptogenesis, and a constituent of myelin sheaths and
cholesterol-rich plasma rafts involved in signal transduction,
covalent binding of cholesterol to Hedgehog morphogens is
a posttranslational modification required for proper activity
of these latter proteins (Edison and Muenke 2004; Guizzetti
and Costa 2007). Sonic hedgehog (Shh) guides cell prolif-
eration, differentiation and morphogenesis of the CNS, cra-
niofacial region, musculoskeletal structures and viscera
during embryonic and fetal development. Reduced cellular
availability of cholesterol results in a drastic decline in Shh
signal transduction in mice (Edison and Muenke 2004).
Ethanol has been shown to inhibit the mevalonate pathway,
and thus cholesterol synthesis (Cottalasso et al. 1998; Li et al.
2007). Furthermore, chicken and mouse embryos exposed
to ethanol displayed reduced Shh signaling (Guizzetti and
Costa 2007). These findings led to the belief that alcohol-
dependent inhibition of the cholesterol-modification of Shh
produces the morphologic defects seen in FAS. To study the
interrelationship among prenatal alcohol exposure, choles-
terol depletion, impairment of Shh signaling and FAS,
investigators commonly use animal models of holoprosen-
cephaly (HPE). HPE is not only the classic brain defect seen
in families with mutations in Shh, but also a manifestation in
severe cases of SLOS and FAS, and can be experimentally
provoked by treating animal embryos with ethanol, inhib-
itors of cholesterol biosynthesis, and inhibitors of Shh signal
transduction (Edison and Muenke 2004; Li et al. 2007;
Lipinski et al. 2010). Li et al. have provided the most
conclusive evidence substantiating the link between choles-
terol deficiency and FAS (Li et al. 2007). They demonstrat-
ed that alcohol treatment of zebrafish embryos caused a
dose-dependent reduction in cholesterol content, decreased
cholesterol-modification of Shh and a loss of Shh signal
transduction, resulting in a FAS-like phenotype (i.e., HPE,
cyclopia, and craniofacial hypoplasia). These alcohol-
induced effects could be rescued by supplementing the
zebrafish embryos with cholesterol.
Retinol deficiency and impaired retinoic acid formation
Retinoic acid (RA) is another eminent morphogen, govern-
ing cell differentiation and early embryonic patterning. RA
is, among others, responsible for proper development of the
craniofacial region and skeleton in vertebrates. In experi-
mental settings, both RA deficiency – either due to a vitamin
A-deficient diet or mutations in RA-synthesizing enzymes –
and RA-receptor defects produce phenotypes strongly
resembling FAS (Deltour et al. 1996; Kot-Leibovich and
Fainsod 2009). Ethanol has been linked to RA depletion as
follows. Retinol – an isoprenoid – is converted to RA in a
two-step oxidative reaction. First, retinol is oxidized by alco-
hol dehydrogenase (ADH), producing the intermediate reti-
naldehyde. Second, retinaldehyde dehydrogenase (RALDH)
catalyzes the conversion of retinaldehyde to RA. Ethanol
detoxification involves identical oxidation steps. Ethanol is
initially oxidized to acetaldehyde through the action of ADH,
followed by formation of acetic acid using ALDH as a cata-
lyst. Evidence is available showing that ethanol competitively
inhibits both ADH and RALDH, resulting in impaired RA
biosynthesis, which leads to developmental malformations
mimicking FAS (Deltour et al. 1996; Kot-Leibovich and
Fainsod 2009). Lack of retinol substrate, e.g., due to lipid
peroxidation, as will be discussed in the following para-
graph, may further thwart RA biosynthesis.
Damage due to reactive oxygen species
Prolonged exposure to ethanol induces the microsomal eth-
anol oxidizing system (cytochrome P450, isoenzyme
CYP2E1), which generates reactive oxygen species (ROS)
(Cottalasso et al. 1998). Although mRNA for P450 2E1
could neither be detected in murine embryos at the time of
gastrulation and neurulation – the developmental stages
during which ethanol exposure causes cerebral and cranio-
facial malformations – nor in human embryonic hepatic
tissue during the first half of gestation (Deltour et al.
1996), this does not exclude microsomal ROS production
at other sites or different developmental stages. Both cho-
lesterol and dolichol are isoprene derivates, and, as such, are
particularly vulnerable to the lipoperoxidative effects of
ethanol-induced ROS. In addition to the consequences of
cholesterol and dolichol depletion outlined above and be-
low, respectively, degradation of these vital membrane con-
stituents affects plasma membrane integrity and vesicular
trafficking (Cottalasso et al. 1998; Guizzetti and Costa
2007). Retinol, and its precursor ß-carotene, also consisting
of isoprene motifs, can equally suffer from ROS attack,
especially in the absence of antioxidants such as vitamin
E, vitamin C and glutathione peroxidase. The generally poor
nutritional state of alcoholic mothers usually entails hypo-
vitaminosis. Also, ethanol has been shown to decrease glu-
tathione peroxidase activity (Cohen-Kerem and Koren
2003). Hence, ethanol intake does not only cause oxidative
stress, it also curtails antioxidant defences. The contribution
of ROS-induced damage to ethanol teratogenesis is substan-
tiated by evidence from several animal studies showing that
supplementation of antioxidants (e.g., vitamin E, flavo-
noids, folic acid, and ß-carotene) attenuates oxidative stress
and, thereby, diminishes fetotoxicity (Cohen-Kerem and
Koren 2003; Wentzel et al. 2006).
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Interference with neural cell adhesion molecules
During embryonic CNS development, neural cell adhesion
molecules (NCAMs) guide processes as neuron-glia inter-
action, synaptogenesis, neuronal migration, growth and
morphogenesis (Miñana et al. 2000). In utero, NCAMs
require posttranslational glycosylation – i.e., the addition
of multiple polysialic acid (PSA) residues, mediated by
sialyltransferase (ST) enzymes in the Golgi apparatus
(GA) – in order to be properly transferred to the plasma
membrane and fulfill their function in enabling neural cell
migration. Prenatal alcohol exposure inhibits ST activity and
leads to cytoplasmic retention of PSA-NCAMs. The resul-
tant reduction in cell surface expression and functionality of
PSA-NCAMs is thought to underlie the migrational errors,
heterotopias and other morphological brain defects seen in
FAS (Miñana et al. 2000). Another important cell adhesion
molecule, regulating cell-cell and cell-matrix interactions
and signaling in the developing brain, is L1CAM, which
belongs to the immunoglobin superfamily. L1CAM contains
21 sites for N-linked glycosylation, a feature that will ac-
quire significance in the following paragraph. Patients with
mutations in L1 display a phenotype known as CRASH
syndrome (Corpus callosum hypoplasia/agenesis, psycho-
motor Retardation, Adducted thumbs, Spastic paraparesis,
Hydrocephalus; MIM *308840). Additional neuropatho-
logic features observed in these patients include hypoplasia
of the cerebellar vermis and ocular anomalies, such as
nystagmus, ptosis, optic nerve hypoplasia and retinal ves-
sel tortuosity. This phenotype is rather reminiscent of FAS.
The supposition that FAS results from ethanol-induced
aberrations in L1 function has gained plausibility by the
observation that ethanol indeed disrupts L1-mediated cell
adhesion and neurite outgrowth in various in vitro studies
(Bearer 2001).
A novel concept
Dolichol deficiency and disruption of protein glycosylation
We are, to our knowledge, the first authors to comprehen-
sively reflect on the concept of FAS exemplifying a congen-
ital disorder of glycosylation (CDG) secondary to prenatal
alcohol exposure. To better understand our theory, we need
to discuss the processes involved in protein glycosylation
(Mohamed et al. 2011a; Achouitar et al. 2011). In N-linked
glycosylation, a branched oligosaccharide chain is cotrans-
lationally assembled on a lipid anchor, i.e., dolichol phos-
phate (Dol-P), attached to the membrane of the endoplasmic
reticulum (ER). The resultant complex is known as lipid-
linked oligosaccharide (LLO). Next, the preassembled oli-
gosaccharide is transferred en bloc to asparagine residues at
glycosylation consensus sites of the nascent protein. The
glycoprotein is subsequently translocated to the GA by
vesicular transport, where several enzymes – of which sia-
lyltransferase (ST), galactosyltransferase (GT), and sialidase
are worthwhile mentioning in the light of the present dis-
cussion – modify the oligosaccharide structure. The final
protein-bound oligosaccharide is conventionally depicted as
a biantennary structure with sialic acid residues at the end of
both antennae. Inherited defects in N-linked glycosylation
are divided in two subtypes (Morava et al. 2008; Mohamed
et al. 2011b; Achouitar et al. 2011). Type I CDG involves
defects in LLO assembly and oligosaccharide transfer to the
nascent protein, resulting in proteins lacking complete oli-
gosaccharides (Mohamed et al. 2011a; Achouitar et al.
2011). Type II CDG encompasses disturbances in the GA-
located processing of the protein-bound oligosaccharide,
usually giving rise to oligosaccharides with truncated anten-
nas. Screening for CDG is performed with isoelectric focus-
ing of the serum glycoprotein transferrin (TIEF) (Morava et
al. 2008; Mohamed et al. 2011b; Achouitar et al. 2011). In
healthy individuals, transferrin predominantly occurs as tet-
rasialotransferrin, for it has two biantennary oligosaccharide
side chains with a total of four terminal sialic acid residues.
A TIEF type I pattern shows decreased tetrasialotransferrin
and increased di- and asialotransferrin, whereas a TIEF type
II pattern additionally features tri- and monosialotransferrin.
Cottalasso et al. demonstrated that ethanol treatment
causes a profound reduction in the dolichol (phosphate)
content of rat liver microsomes and GA (Cottalasso et al.
1998). They also showed that the mechanism underlying
this decrease involves both inhibition of dolichol biosynthe-
sis (i.e., the mevalonate pathway) and dolichol peroxidation
due to ROS. A sufficient level of microsomal Dol-P is a
prerequisite for the initiation of N-linked glycosylation.
Thus, ethanol exposure may seriously impede glycoprotein
synthesis and secretion during fetal life. Ethanol also affects
mannosyltransferase (MT) activity, an enzyme mediating
mannosylation of Dol-P during the build-up of the LLO
(Cottalasso et al. 1998). Furthermore, ST and GT are
inhibited, while sialidase activity is stimulated in response
to ethanol administration (Cottalasso et al. 1998; Flahaut et
al. 2003). These latter effects of ethanol, causing disruption
of terminal sialylation during the second phase of N-linked
glycosylation in the GA, are probably of minor importance,
considering that carbohydrate-deficient transferrin (CDT) –
the best indicator of chronic alcohol abuse currently avail-
able – mainly consists of di- and asialotransferrin (type I
TIEF pattern), indicating defects in LLO assembly during
the first phase of N-linked glycosylation in the ER
(Landberg et al. 1995; Flahaut et al. 2003). We recently
witnessed a transiently abnormal (type I) IEF pattern of
serum transferrin and α1-AT in a male newborn at the age
of one week, screened for CDG because of hypotonia,
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dysmorphic features, hypoglycemia, elevated liver enzymes,
and spasticity. At the age of three months, IEF patterns were
normal. Following confirmation of maternal alcohol abuse
during pregnancy, FAS was diagnosed. We speculate that
the anomalous IEF patterns observed shortly after birth were
due to ethanol-induced glycosylation defects in utero.
Tomás et al. reported that the glycosylation machinery is
indeed targeted by ethanol in rat astrocytes, thereby puta-
tively disrupting brain development. Deleterious effects of
ethanol on the glycosylation process have also been dem-
onstrated in hepatocytes and neurons (Tomás et al. 2002).
The link between ethanol-induced glycosylation defects and
the (neuro)developmental perturbations seen in FAS is easily
understood when one realizes that many proteins involved in
cell recognition, adhesion, migration and signaling are in fact
glycoproteins. Among these are L1, PSA-NCAM, Notch, α-
dystroglycan, and various growth factor receptors (Tomás et
al. 2002; Edison and Muenke 2004; Achouitar et al. 2011).
There are many phenotypic similarities between FAS and
CDG. Both are generally characterized by growth retarda-
tion, developmental delay, intellectual disability, ataxia, hy-
potonia, seizures, and dysmorphic facial features (e.g.,
hypertelorism, short upturned nose, malformed ears, and
midface hypoplasia). Neuropathologic resemblances include
microcephaly, cerebral atrophy, cerebellar (vermis) hypopla-
sia, corpus callosum hypoplasia/agenesis, and migration
errors (Jones and Smith 1973; Van Balkom et al. 1996;
Chudley et al. 2005; Morava et al. 2009; Achouitar et al.
2011). Of special interest are the ocular anomalies common
to both entities. Coloboma, microphthalmia (causing short
Fig. 1 Integrated pathophysio-
logical model of fetal alcohol
syndrome (FAS). ADH, alcohol
dehydrogenase; RALDH,
retinaldehyde dehydrogenase;
LLO, lipid-linked oligosaccha-
ride; CNS, central nervous
system; PSA-NCAM, polysialic
acid neural cell adhesion
molecules; L1CAM, L1 cell
adhesion molecule
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palpebral fissures), optic nerve hypoplasia, nystagmus, and
strabismus (esotropia) are frequently observed in patients
with FAS (Abdelrahman and Conn 2009). Uveal coloboma
and microphthalmia serve as measures of effect in murine
models of ethanol teratogenicity (Parnell et al. 2006). All
these eye abnormalities are also encountered in CDG
patients (Morava et al. 2010; Achouitar et al. 2011;
Mohamed et al. 2011a). We have to note that certain non-
structural abnormalities specific to CDG, e.g., coagulopathy
and endocrinopathy, are not present in FAS, because active
disruption of glycosylation ceases at birth in the latter, after
which proper synthesis of coagulatory and hormonal glyco-
proteins presumably resumes.
A unifying theory and future directions
We propose an integrated pathophysiological model for the
development of FAS (Fig. 1), incorporating all previously
mentioned mechanisms. We emphasize the central role of
ethanol-induced disruption of isoprenoid metabolism.
Deficient biosynthesis and increased degradation of impor-
tant isoprene derivatives (cholesterol, dolichol, and retinol)
contribute to the pathogenesis of FAS.
Although various components of our model have already
been tested, as described above, further studies could
corroborate the pivotal role of perturbed isoprenoid metab-
olism in FAS. HMG-CoA reductase inhibitors (statins) and
nitrogen-containing bisphosphonates inhibit crucial enzymes
in the mevalonate pathway, thereby downregulating the bio-
synthesis of dolichol and cholesterol. Lipophilic statins have
been shown to reach the embryo when ingested by pregnant
women (Edison and Muenke 2004). Offspring of animals
gestationally exposed to (high doses of) these drugs can be
monitored for the development of a phenotype mimicking
FAS. It should be noted that rodents are not suitable for
these experiments, since these animals are not susceptible to
the cholesterol-lowering effects of statins (Edison and
Muenke 2004). In vitro and in vivo studies are needed, in
which cholesterol, dolichol, and/or β-carotene/retinol are
administered simultaneously with ethanol in order to assess
whether these isoprenoid substances ameliorate ethanol-
inflicted abnormalities. IEF can be used to detect abnormal
glycosylation of several glycoproteins (e.g., transferrin, α1-
AT, and thyroglobulin) in the (cord) blood of newborns with
characteristic FAS features and a history of maternal gesta-
tional alcohol abuse. Inasmuch as the ethanol-induced CNS
and craniofacial malformations are thought to originate dur-
ing gastrulation and neurulation, it may be valuable to
determine the microsomal Dol-P level, MT activity, and
glycosylation status of several glycoproteins (PSA-NCAM,
L1, growth factor receptors) in early embryonic neuronal
tissue of an animal model of FAS. Furthermore, when
alcohol ‘goes in’ pregnant women and animals, various
antioxidants may be used to prevent ‘strange things coming
out’ of them. Finally, we suggest to consider the possibility
of maternal alcohol abuse during pregnancy in newborns
with transient glycosylation abnormalities.
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